Randomized, Double-Blind Phase Iii Study Of Pazopanib Versus Placebo In Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence Of Disease Following Metastasectomy: A Trial Of The Ecog-Acrin Cancer Research Group (E2810).
JOURNAL OF CLINICAL ONCOLOGY(2019)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要